HCA Healthcare, Inc. $HCA Shares Acquired by Fortis Capital Advisors LLC

Fortis Capital Advisors LLC lifted its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 5.7% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 2,347 shares of the company’s stock after buying an additional 126 shares during the quarter. Fortis Capital Advisors LLC’s holdings in HCA Healthcare were worth $899,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in HCA. Ascent Group LLC increased its position in HCA Healthcare by 5.0% during the 2nd quarter. Ascent Group LLC now owns 10,086 shares of the company’s stock worth $3,864,000 after purchasing an additional 479 shares in the last quarter. Ameritas Advisory Services LLC purchased a new stake in HCA Healthcare during the 2nd quarter worth about $153,000. Hilltop National Bank purchased a new stake in HCA Healthcare during the 2nd quarter worth about $156,000. Mirae Asset Global Investments Co. Ltd. increased its position in HCA Healthcare by 4.9% during the 2nd quarter. Mirae Asset Global Investments Co. Ltd. now owns 24,837 shares of the company’s stock worth $9,515,000 after purchasing an additional 1,153 shares in the last quarter. Finally, Metropolis Capital Ltd increased its position in HCA Healthcare by 76.6% during the 2nd quarter. Metropolis Capital Ltd now owns 603,029 shares of the company’s stock worth $231,020,000 after purchasing an additional 261,592 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Activity

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the company’s stock in a transaction that occurred on Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the transaction, the executive vice president directly owned 31,503 shares of the company’s stock, valued at $13,194,716.52. This represents a 10.85% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 1.30% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several research firms have commented on HCA. Wall Street Zen upgraded HCA Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, July 5th. Truist Financial lifted their price target on HCA Healthcare from $390.00 to $415.00 and gave the company a “buy” rating in a report on Wednesday, July 16th. Royal Bank Of Canada lowered their price target on HCA Healthcare from $404.00 to $401.00 and set an “outperform” rating for the company in a report on Monday, July 28th. Weiss Ratings restated a “buy (b-)” rating on shares of HCA Healthcare in a report on Saturday, September 27th. Finally, Wells Fargo & Company reduced their price objective on HCA Healthcare from $385.00 to $375.00 and set an “equal weight” rating on the stock in a research note on Thursday, August 14th. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and nine have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $407.75.

HCA Healthcare Price Performance

NYSE HCA opened at $429.52 on Friday. The business’s 50-day simple moving average is $397.53 and its 200-day simple moving average is $372.39. The firm has a market capitalization of $100.50 billion, a P/E ratio of 18.05, a P/E/G ratio of 1.34 and a beta of 1.40. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $432.36.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Friday, July 25th. The company reported $6.84 EPS for the quarter, topping the consensus estimate of $6.20 by $0.64. The firm had revenue of $18.61 billion for the quarter, compared to analyst estimates of $18.49 billion. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.HCA Healthcare’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same period in the previous year, the company posted $5.50 EPS. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, equities research analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th were given a dividend of $0.72 per share. The ex-dividend date of this dividend was Tuesday, September 16th. This represents a $2.88 annualized dividend and a yield of 0.7%. HCA Healthcare’s payout ratio is 12.11%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.